In a subsequent study, the same researchers demonstrated that GPR3 messenger RNA (mRNA) levels were elevated in 18 post-mortem brain tissue of AD patients (Thathiah et al., 2013). This evidence concerns the gene GPR3 and Alzheimer disease.